Atossa Therapeutics, Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.6876

+0.0366 (5.62%)

At close: Apr 2, 2025, 4:00 PM

0.6829

-0.0047 (-0.69%)

After-hours: Apr 2, 2025, 7:57 PM EDT

Atossa Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-25.5	-30.09	-26.96	-20.61	-17.83	Upgrade
Depreciation & Amortization	0.02	0.02	0.01	0.02	0.05	Upgrade
Loss (Gain) From Sale of Assets	0.01	-	-	-	-	Upgrade
Loss (Gain) From Sale of Investments	1.71	2.99	-	-	-	Upgrade
Stock-Based Compensation	2.29	4.62	6.79	5.27	3.02	Upgrade
Other Operating Activities	-	-	0	-	3.3	Upgrade
Change in Accounts Payable	-0.13	-2.16	1.25	0.13	1.3	Upgrade
Change in Other Net Operating Assets	0.58	3.68	-1.85	-1.28	-1.41	Upgrade
Operating Cash Flow	-21.03	-20.94	-20.76	-16.47	-11.57	Upgrade
Capital Expenditures	-0.02	-0.01	-0.03	-0.01	-0.01	Upgrade
Investment in Securities	-	-	-4.7	-	-	Upgrade
Investing Cash Flow	-0.02	-0.01	-4.73	-0.01	-0.01	Upgrade
Issuance of Common Stock	3.67	-	-	113.88	33.62	Upgrade
Repurchase of Common Stock	-	-1.48	-	-0.57	-0.01	Upgrade
Financing Cash Flow	3.67	-1.48	-	113.3	38.55	Upgrade
Net Cash Flow	-17.38	-22.43	-25.49	96.82	26.97	Upgrade
Free Cash Flow	-21.05	-20.96	-20.79	-16.48	-11.58	Upgrade
Free Cash Flow Per Share	-0.17	-0.17	-0.16	-0.14	-1.02	Upgrade
Levered Free Cash Flow	-14.86	-11.76	-10.54	-21.72	6.82	Upgrade
Unlevered Free Cash Flow	-14.86	-11.76	-10.54	-21.72	6.82	Upgrade
Change in Net Working Capital	-0.12	-3.22	0	14.17	-12.89	Upgrade

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q